ebm

91
EBM Dr. Nada AlYousefi April 25, 2012

Upload: taro

Post on 13-Jan-2016

43 views

Category:

Documents


0 download

DESCRIPTION

EBM. Dr. Nada AlYousefi April 25, 2012. Motivation: EBM “Successes”. Theophylline and asthma We were doing the wrong thing Littenberg, 1988 Beta blockers and MIs We weren’t doing the right thing Yusuf, 1987. Uses of “EBM”. Use of empirically-verified treatments in the care of patients - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: EBM

EBMDr. Nada AlYousefiApril 25, 2012

Page 2: EBM

Motivation: EBM “Successes”

•Theophylline and asthma▫We were doing the wrong thing

Littenberg, 1988

•Beta blockers and MIs▫We weren’t doing the right thing

Yusuf, 1987

Page 3: EBM

Uses of “EBM”

•Use of empirically-verified treatments in the care of patients

•Incorporation of research results into the process of care

•Ability to critically appraise research results

Page 4: EBM

What is Evidence-Based Medicine?

•“The integration of individual clinical expertise with the best available clinical evidence from systematic research.”

David L Sackett, W Scott Richardson, William Rosenberg, R Brian Haynes Evidence Based Medicine--How to Practice and Teach EBM, 1996

▫Various definitions

Page 5: EBM

About 1/3 of worthwhile

evidence is eventually refuted

or attenuated

About 10% of published evidence

is worth reading

About 1/2 of relevant evidence is

not implemented

Page 6: EBM
Page 7: EBM

5 A’s

Steps of ebm

Page 8: EBM

AppraisedAppraised TopicTopicTopicTopic::A subject of discussion or conversation

AppraiseAppraise::To evaluate, & estimate the quality, amountof validity, results and applicability

CriticalCritical::careful, exact evaluation and judgment

CriticallyCritically

Page 9: EBM

“Best Available Clinical Evidence”•Therapy

▫Double-blind, placebo-controlled, randomized clinical trial

•Diagnosis▫Independent, blind comparison with a

reference standard•Prognosis

▫Representative and well-defined prospective cohort of patients at a similar point in the course of disease

•See Centre for Health Evidence

Page 10: EBM

Levels of Evidences• (I-1) a well done systematic review of 2 or more

RCTs

• (I-2) a RCT

• (II-1) a cohort study

• (II-2) a case-control study

• (II-3) a dramatic uncontrolled experiment

• (III) respected authorities, expert committees, etc..

• (IV) ...someone once told me.... http://www.phru.org/casp/ See also AAFP

Page 11: EBM

“Systematic Research”

•“Meta-analysis”

•“Literature synthesis”

▫From Michael Scriven

Page 12: EBM

Questions

ARIF

Page 13: EBM

Centre for EBM: http://163.1.212.5/docs/focusquest.html

Questions: PICO

Page 14: EBM

Problems• Should a 30-year-old

woman with recurrent uncomplicated lower UTIs be advised to drink cranberry juice to prevent reinfection?

• For a 63 year old woman with Type 2 diabetes, is gabapentin superior to amitriptyline as first-line therapy for painful peripheral neuropathy?

Page 15: EBM

Presentation will cover:• Relavance• PICO• search strategy• search results• the validity of this

evidence• the importance of

this valid evidence• can this valid,

important evidence be applied to your patient

Page 16: EBM

Task•Well formulated question?•Formulate the query•Report back to us on your success•The whole group reports back in a week

Page 17: EBM

Search for the Best Evidence

•Review articles•Community/professional standards•Systematic reviews•Original results

Page 18: EBM

What are the Sources of Good Evidence?

www.welch.jhu.edu

Page 19: EBM
Page 20: EBM

http://ksu.edu.sa/Deanships/library/Pages/Home.aspxhttp://ksu.edu.sa/Deanships/library/Pages/Home.aspx

Page 21: EBM
Page 22: EBM

http://http://saudi.digitallibraryplus.comsaudi.digitallibraryplus.com

Page 23: EBM

National Guideline Clearinghouse

www.guideline.gov

Website

Page 24: EBM
Page 25: EBM
Page 26: EBM

CochraneWebsite

Page 27: EBM
Page 28: EBM
Page 29: EBM
Page 30: EBM

TRIP Database

www.tripdatabase.com(75 resources)…

Website

Page 31: EBM
Page 32: EBM
Page 33: EBM

UpToDate

Website

Page 34: EBM
Page 35: EBM
Page 36: EBM

Getting to PubMed

Page 37: EBM

PubMed Response

Page 38: EBM

PubMed Clinical Query

www4.ncbi.nlm.nih.gov/PubMed/

Page 39: EBM

PubMed, Clinical Query, cont’d

Question

Context

Subject matter

Website

Page 40: EBM

Controlled Vocabulary for Subject Matter

Page 41: EBM

www.ncbi.nlm.nih.gov/pubmedwww.ncbi.nlm.nih.gov/pubmed

Page 42: EBM

•Key concepts!•Auther

Page 43: EBM

Stopwords

Page 44: EBM

MeSH(The Medical Subject Headings )

Page 45: EBM

Exercise

•Use the MeSH Database to build a strategy that will find citations to references discussing the economics of community-acquired pneumonia.

Page 46: EBM

Exercise

•Use the NLM Catalog Journal search page to see if PubMed includes the journal, Molecular Microbiology. If so, retrieve all PubMed citations from this journal.

Page 47: EBM

Exercise

•Use the Clinical Queries to find systematic reviews for accidents caused by sleep deprivation.

Page 48: EBM

Search

•What role does pain have in sleep disorders?

Page 49: EBM

Search

•To search for citations to articles written by Bonnie W. Ramsey about gene therapy for cystic fibrosis

Page 50: EBM

Search

•To search for citations to articles about drosophila in the journal Molecular Biology of the Cell

Page 51: EBM

Exercise

•Find citations to articles about the ethics of liver transplantation. Check Details to see how the terms are mapped. Filter to review articles. Select a few items and add them to the Clipboard. Go to the Clipboard and view the selected items in Abstract format to see the assigned MeSH terms.

Page 52: EBM

Exercise

•Use the MeSH Database to build a strategy that will find citations to articles about schizophrenia resulting from prenatal exposure to influenza. Schizophrenia and influenza should be the major topics of the articles.

Page 53: EBM

line Time

Types of Studies

Case ControlCase Control

Cross Cross SectionalSectional

Clinical TrialClinical Trial

Cohort studyCohort study

`Case SeriesCase Series

CaseReport

Page 54: EBM

Types of Epidemiological Studies•Observational

Case Reports, Case series Cross - Sectional Case- Control Cohort

•Interventional Clinical Trials

Page 55: EBM

Systematic review of RCTsSystematic review of RCTs

RCT

Cohort

Case control

InterventionalInterventional

ObservationaObservationall

validity

Page 56: EBM
Page 57: EBM
Page 58: EBM

What’s A Paper on Therapy?•Clinical Trial (Controlled) Compares

INTERVENTION

with CONTROL

Page 59: EBM

Clinical Trial Compares– INTERVENTION

Drug (New) Structured exercise program (e.g. osteoporosis) Surgical procedure

– CONTROL Placebo, old drug or old intervention Usual regular advise given (osteoporosis) Another surgical procedure / No surgery

Page 60: EBM

Preparation: Randomization, Computer generated list

Eligibility assessment (Inclusion/exclusion) Consent Allocation to study arms (Concealment) Baseline assessment Initiation of intervention (Blind) Follow-up Outcome assessment Data analysis

process of RCTs

Page 61: EBM
Page 62: EBM

Appraise the Evidence• Assess validity? Correctness )likely

to be true(

• What are the results? Clinically

important

• Can we apply the results to our patient? Applicable in and useful for my patients

Page 63: EBM

April 21, 2023

EBM

Jeddah Working

Group

64

Page 64: EBM

VALIDITYRandomization.Concealment. Blindness. Follow up complete.Intention to treat.Similar groups at start.Both groups treated equally.

Page 65: EBM

Randomization Randomisation = similar groups at

baseline Equal (50%) chance to be in either groupHow was it randomized?Was randomization concealed?

- selection- allocation

Page 66: EBM

concealed allocation

Did investigators know to which group the potential subject would be assigned before enrolling them?

Trials with unconcealed allocation consistently overestimate benefit by ~40%

Page 67: EBM

Selection bias

Reduced by: centralised randomisation on-site computer system with group

assignments in a locked file sequentially numbered, sealed, opaque

envelopes

Not: alternation, dates of birth, day of week.

Page 68: EBM

BlindnessWho is Blind?

- Physicians-Nurses-Patients-Data gathering staff- data analyzers.

- Single, double…

Page 69: EBM

Blindness•If patient knows: Placebo effect

Those who are on effective treatment perform better than those who receive Placebo

•If Physician knows: Overestimate Treatment effect (More care, Co-intervention)

Page 70: EBM

Rx

C

Potential Subjects

Intervention starts

Outcome

Follow-up

• Selection bias • Performance bias

BlindnessConcealed Allocation

Page 71: EBM

● duration of study.

● drop out < 20%.

Page 72: EBM

All patients analyzed in the groups to which they were allocated

Page 73: EBM

INTENTION TO TREAT (ITT)

200

100 100

50 70

3050

4040 IMPROVED

80%

OR

40%

57%

OR

40%

Drop out Drop out

intervention

control

Page 74: EBM

Sources of bias in trials

Target population

Allocation

Selection bias

Performance bias

Attrition bias

Detection bias

Intervention Control

group(A) group

(B) Not exposed Exposed

Follow-up Follow-up

Outcomes Outcomes

Page 75: EBM

Two balanced groups:

• Start Balanced: All prognostic factors are equally distributed at the start (Concealed Randomization)

• Run Balanced: All prognostic factors are maintained balanced throughout the study (Blindness and the 3C)

• End Balanced: All prognostic factors are maintained balanced at the end of the study (ITT)

Intervention

Page 76: EBM

Therapy• ARR•RR

•RRR•NNT•CI

Page 77: EBM

Result•Result Experimental Event Rate (EER)

Risk (or chance) of outcome event in experimental group

•Results control event rate (CER) Risk (or chance) of outcome event in

control group.

78

Page 78: EBM

Result

Relative Risk (RR)•A measure of the chance of the event

occurring in the experimental group relative to it occurring in the control group.

•RR = EER / CER

79

Page 79: EBM

•RRR=CER-EER/CER

•A RRR of 25% means that the new treatment reduced the risk of death by 25% relative to that occurring among control patients; the greater the relative risk reduction, the more effective the therapy.

Relative Risk Reduction (RRR ):.

Page 80: EBM

•The absolute difference between the risk of the event in the control and experimental groups.

•ARR = CER – EER

Absolute Risk Reduction (ARR)

Page 81: EBM

•Measure of clinical significance

•How many pat’s have to be treated with intervention in order one patient Would expected to benefit.

• NNT=1/ARR

•Conversely, can do number needed to harm▫uses harmful outcomes, eg death, weight gain

Number needed to treat (NNT)

Page 82: EBM

Magnitude (treatment Magnitude (treatment effect)effect):

•Absolute effects (ARR & NNT)•Relative effects (RR, RRR )

Precision:Precision:oP value.P value.•Confidence interval?

Page 83: EBM

Result Tabulation

Event Event

+ Ve+ VeEventEvent

- Ve- VeTotalTotal

ExperimentExperimental al

aabba+ba+b

ControlControlccddc+dc+d

•EER = Experimental Event Rate (a/a+b)

•CER = Control Event Rate (c/c+d)

Page 84: EBM

BleedinBleedingg

presentpresent

BleedingBleeding

AbsentAbsentTotalTotal

Drug ADrug A 20208080100100Drug BDrug B40406060100100

•EER-A (Risk A) = 20/100 = 20% (0.2)•CER-B (Risk B) = 40/100 = 40% (0.4)

Page 85: EBM

ARR = CER - EER

NNT = 1 / ARR

RR = EER/CER (Risk A/Risk B)

RRR = 1- RR

Page 86: EBM

BleedinBleedingg

presentpresent

BleedingBleeding

AbsentAbsentTotalTotal

Drug ADrug A 20208080100100Drug BDrug B40406060100100

•ARR = CER - EER

NNT = 1 / ARR

•RR = EER/CER

RRR = 1- RR

Page 87: EBM

ARR = CER – EER = 0.4 – 0.2 =

0.2 (20%)

NNT = 1 / ARR = 1/0.2 = 5

RR = EER/CER = 0.2/0.4 =

0.5

RRR = 1- RR = 1- 0.5=

0.5 (50%)

Page 88: EBM

Confidence intervals?•The range within which the likelihood of a true value is expected to be within a given degree of certainty, usually evaluated at 95% CI.

•Precision

Page 89: EBM
Page 90: EBM

Summary•Validity - is the paper

likely to be true

•Importance - size of effect▫NNT ▫Percision

•Applicability - can it work for me/my setting

91

Page 91: EBM